Literature DB >> 30662618

FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy.

Shuoqiang Hu1, Shujun Cao1, Zichuan Tong1, Jinghua Liu2.   

Abstract

AIMS: Fibroblast growth factor 21 (FGF21) plays a critical role in protecting against myocardial ischemia/reperfusion (I/R) injury. However, the molecular mechanism is not completely understood. Here, we aimed to examine whether miRNA-145 (miR-145) is involved in FGF21 protection against myocardial I/R injury through angiopoietin-2 (Angpt2) and autophagy.
METHODS: We established a rat myocardial I/R model and H9c2 hypoxia/reoxygenation (H/R) model. After administration of FGF21 in the rat I/R model, the infarct size, morphological changes and apoptosis in myocardium were determined by 2,3,5-triphenyltetrazolium chloride (TTC), hematoxylin and eosin (HE), and Masson's trichrome staining, and TUNEL assay, respectively. The expression levels of miR-145 and Angpt2 were evaluated by quantitative real-time PCR (qRT-PCR), Western blotting and immunohistochemical (IHC) staining. The activity of lactate dehydrogenase (LDH), TNF-α and IL-6 were assayed. Using a dual-luciferase reporter system, the targeted role of miR-145 on Angpt2 was studied. After transfection with miR-145 inhibitor, H9c2 cells were subjected to stimulated H/R with or without FGF21 treatment. The expression of Angpt2 was assessed while cell apoptosis and cell migration assays were performed.
RESULTS: FGF21 significantly decreased infarction after I/R, ameliorated I/R-induced cell apoptosis, and inhibited I/R-induced LDH, TNF-α and IL-6 in serum. FGF21 inhibited I/R-induced decrease in miR-145 level, increase in Angpt2 expression and decrease in autophagy; FGF21 also upregulated LC3-B and Beclin1 levels. miR-145 directly targeted Angpt2. The roles of FGF21 in expression of miR-145 and Angpt2 and activation of autophagy after H/R were reversed by miR-145 inhibitor. In addition, the FGF21-inhibited cell apoptosis and FGF21-promoted migration after H/R were restored by miR-145 inhibitor.
CONCLUSION: FGF21 protects myocardial cells against I/R injury by promoting an increase in miR-145 levels and autophagy while inhibiting Angpt2 expression, suggesting a novel therapeutic strategy for protecting against myocardial I/R injury.

Entities:  

Keywords:  Angpt2; FGF21; autophagy; miR-145; myocardial ischemia-reperfusion injury

Year:  2018        PMID: 30662618      PMCID: PMC6291727     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  19 in total

1.  MiR-29b-3p aggravates cardiac hypoxia/reoxygenation injury via targeting PTX3.

Authors:  Dan He; Lei Yan
Journal:  Cytotechnology       Date:  2021-01-05       Impact factor: 2.058

Review 2.  Exploring the role of non-coding RNAs in autophagy.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Mahdi Mohaqiq; Jamal Majidpoor; Mohammad Amin Moosavi; Mohammad Taheri
Journal:  Autophagy       Date:  2021-02-18       Impact factor: 13.391

3.  The protective effects of phosphodiesterase-5 inhibitor, sildenafil on post-resuscitation cardiac dysfunction of cardiac arrest: by regulating the miR-155-5p and miR-145-5p.

Authors:  Yong He; Guoxing Wang; Chuang Li; Yuxing Wang; Qian Zhang
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-01-06       Impact factor: 2.953

4.  Serum fibroblast growth factor 21 levels after out of hospital cardiac arrest are associated with neurological outcome.

Authors:  Pirkka T Pekkarinen; Markus B Skrifvars; Ville Lievonen; Pekka Jakkula; Laura Albrecht; Pekka Loisa; Marjaana Tiainen; Ville Pettilä; Matti Reinikainen; Johanna Hästbacka
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Co‑expression of tissue kallikrein 1 and tissue inhibitor of matrix metalloproteinase 1 improves myocardial ischemia‑reperfusion injury by promoting angiogenesis and inhibiting oxidative stress.

Authors:  Shujie Huang; Meixian Chen; Huizhen Yu; Kaiyang Lin; Yansong Guo; Pengli Zhu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

6.  Randomized controlled clinical study on Yiqi Liangxue Shengji prescription for intervention cardiac function of acute myocardial infarction with ischemia-reperfusion injury.

Authors:  Cong Chen; JunYan Xia; Ruli Feng; Jie Wan; Kun Zhou; Qian Lin; Dong Li
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

Review 7.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

8.  MicroRNA-145-5p inhibits hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes by targeting ROCK1.

Authors:  Chao Cheng; Dong-Ling Xu; Xiao-Bo Liu; Shao-Jie Bi; Juan Zhang
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

Review 9.  Novel Mechanisms of Exercise-Induced Cardioprotective Factors in Myocardial Infarction.

Authors:  Yuan Guo; Jingyuan Chen; Haihua Qiu
Journal:  Front Physiol       Date:  2020-03-10       Impact factor: 4.566

10.  MiR-21 mediates the protection of kaempferol against hypoxia/reoxygenation-induced cardiomyocyte injury via promoting Notch1/PTEN/AKT signaling pathway.

Authors:  Jinxi Huang; Zhenhui Qi
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.